An open-label, multicenter, multiple-dose study to determine the optimum starting dose of C.E.R.A. (continuous erythropoietin receptor activator-methoxy polyethylene glycol-epoetin beta) for maintenance treatment of anemia in pediatric patients with chronic kidney disease (CKD) on hemodialysis (HD) (NH19707, NCT00717366)

Category Primary study
JournalPediatric Nephrology
Year 2016
This article has no abstract
Epistemonikos ID: 9ecb64e5690c6f7e411ecda30603b36bad2349f6
First added on: Feb 07, 2025